191 related articles for article (PubMed ID: 9378499)
1. Unmethylated CpG-containing oligodeoxynucleotides inhibit apoptosis in WEHI 231 B lymphocytes induced by several agents: evidence for blockade of apoptosis at a distal signalling step.
Macfarlane DE; Manzel L; Krieg AM
Immunology; 1997 Aug; 91(4):586-93. PubMed ID: 9378499
[TBL] [Abstract][Full Text] [Related]
2. CpG oligodeoxyribonucleotides rescue mature spleen B cells from spontaneous apoptosis and promote cell cycle entry.
Yi AK; Chang M; Peckham DW; Krieg AM; Ashman RF
J Immunol; 1998 Jun; 160(12):5898-906. PubMed ID: 9637502
[TBL] [Abstract][Full Text] [Related]
3. The arthritogenic and immunostimulatory properties of phosphorothioate oligodeoxynucleotides rely on synergy between the activities of the nuclease-resistant backbone and CpG motifs.
Bjersing JL; Eriksson K; Tarkowski A; Collins LV
Inflammation; 2004 Feb; 28(1):39-51. PubMed ID: 15072229
[TBL] [Abstract][Full Text] [Related]
4. Bacterial DNA delays human eosinophil apoptosis.
Ilmarinen P; Hasala H; Sareila O; Moilanen E; Kankaanranta H
Pulm Pharmacol Ther; 2009 Jun; 22(3):167-76. PubMed ID: 19073274
[TBL] [Abstract][Full Text] [Related]
5. CpG-oligodeoxynucleotide-resistant variant of WEHI 231 cells.
Manzel L; Macfarlane DE
J Leukoc Biol; 1999 Nov; 66(5):817-21. PubMed ID: 10577514
[TBL] [Abstract][Full Text] [Related]
6. CpG DNA rescue from anti-IgM-induced WEHI-231 B lymphoma apoptosis via modulation of I kappa B alpha and I kappa B beta and sustained activation of nuclear factor-kappa B/c-Rel.
Yi AK; Krieg AM
J Immunol; 1998 Feb; 160(3):1240-5. PubMed ID: 9570540
[TBL] [Abstract][Full Text] [Related]
7. Toll-like receptor agonists induce apoptosis in mouse B-cell lymphoma cells by altering NF-κB activation.
Arunkumar N; Liu C; Hang H; Song W
Cell Mol Immunol; 2013 Jul; 10(4):360-72. PubMed ID: 23727784
[TBL] [Abstract][Full Text] [Related]
8. CpG DNA rescue of murine B lymphoma cells from anti-IgM-induced growth arrest and programmed cell death is associated with increased expression of c-myc and bcl-xL.
Yi AK; Hornbeck P; Lafrenz DE; Krieg AM
J Immunol; 1996 Dec; 157(11):4918-25. PubMed ID: 8943396
[TBL] [Abstract][Full Text] [Related]
9. Impact of modifications of heterocyclic bases in CpG dinucleotides on their immune-modulatory activity.
Vollmer J; Weeratna RD; Jurk M; Davis HL; Schetter C; Wüllner M; Wader T; Liu M; Kritzler A; Krieg AM
J Leukoc Biol; 2004 Sep; 76(3):585-93. PubMed ID: 15218053
[TBL] [Abstract][Full Text] [Related]
10. Antitumor effect of c-myc antisense phosphorothioate oligodeoxynucleotides on human melanoma cells in vitro and and in mice.
Leonetti C; D'Agnano I; Lozupone F; Valentini A; Geiser T; Zon G; Calabretta B; Citro G C; Zupi G
J Natl Cancer Inst; 1996 Apr; 88(7):419-29. PubMed ID: 8618233
[TBL] [Abstract][Full Text] [Related]
11. G3139 and other CpG-containing immunostimulatory phosphorothioate oligodeoxynucleotides are potent suppressors of the growth of human tumor xenografts in nude mice.
Gekeler V; Gimmnich P; Hofmann HP; Grebe C; Römmele M; Leja A; Baudler M; Benimetskaya L; Gonser B; Pieles U; Maier T; Wagner T; Sanders K; Beck JF; Hanauer G; Stein CA
Oligonucleotides; 2006; 16(1):83-93. PubMed ID: 16584297
[TBL] [Abstract][Full Text] [Related]
12. CpG stimulation of primary mouse B cells is blocked by inhibitory oligodeoxyribonucleotides at a site proximal to NF-kappaB activation.
Lenert P; Stunz L; YI AK; Krieg AM; Ashman RF
Antisense Nucleic Acid Drug Dev; 2001 Aug; 11(4):247-56. PubMed ID: 11572601
[TBL] [Abstract][Full Text] [Related]
13. CpG oligodeoxynucleotides induce cyclooxygenase-2 in human B lymphocytes: implications for adjuvant activity and antibody production.
Bernard MP; Phipps RP
Clin Immunol; 2007 Nov; 125(2):138-48. PubMed ID: 17728187
[TBL] [Abstract][Full Text] [Related]
14. Antagonism of immunostimulatory CpG-oligodeoxynucleotides by quinacrine, chloroquine, and structurally related compounds.
Macfarlane DE; Manzel L
J Immunol; 1998 Feb; 160(3):1122-31. PubMed ID: 9570525
[TBL] [Abstract][Full Text] [Related]
15. Antagonism of immunostimulatory CpG-oligodeoxynucleotides by 4-aminoquinolines and other weak bases: mechanistic studies.
Manzel L; Strekowski L; Ismail FM; Smith JC; Macfarlane DE
J Pharmacol Exp Ther; 1999 Dec; 291(3):1337-47. PubMed ID: 10565859
[TBL] [Abstract][Full Text] [Related]
16. CpG Oligodeoxynucleotides Induces Apoptosis of Human Bladder Cancer Cells via Caspase-3-Bax/Bcl-2-p53 Axis.
Luo Y; Fu X; Ru R; Han B; Zhang F; Yuan L; Men H; Zhang S; Tian S; Dong B; Meng M
Arch Med Res; 2020 Apr; 51(3):233-244. PubMed ID: 32139108
[TBL] [Abstract][Full Text] [Related]
17. Inhibitory oligonucleotides specifically block effects of stimulatory CpG oligonucleotides in B cells.
Stunz LL; Lenert P; Peckham D; Yi AK; Haxhinasto S; Chang M; Krieg AM; Ashman RF
Eur J Immunol; 2002 May; 32(5):1212-22. PubMed ID: 11981808
[TBL] [Abstract][Full Text] [Related]
18. CpG oligodeoxynucleotides rescue BKS-2 immature B cell lymphoma from anti-IgM-mediated growth inhibition by up-regulation of egr-1.
Han SS; Chung ST; Robertson DA; Chelvarajan RL; Bondada S
Int Immunol; 1999 Jun; 11(6):871-9. PubMed ID: 10360960
[TBL] [Abstract][Full Text] [Related]
19. Inhibitory oligonucleotides block the induction of AP-1 transcription factor by stimulatory CpG oligonucleotides in B cells.
Lenert P; Yi AK; Krieg AM; Stunz LL; Ashman RF
Antisense Nucleic Acid Drug Dev; 2003; 13(3):143-50. PubMed ID: 12954114
[TBL] [Abstract][Full Text] [Related]
20. CpG oligodeoxynucleotide 1826 enhances the Lewis lung cancer response to radiotherapy in murine tumor.
Yuan S; Qiao T; Chen W
Cancer Biother Radiopharm; 2011 Apr; 26(2):203-8. PubMed ID: 21539452
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
